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Activation of the stimulator of interferon genes
(STING) pathway by microbial or self-DNA, as well
as cyclic dinucleotides (CDNs), results in the induc-
tion of numerous genes that suppress pathogen
replication and facilitate adaptive immunity. Howev-
er, sustained gene transcription is rigidly prevented
to avoid lethal STING-dependent proinflammatory
disease by mechanisms that remain unknown. We
demonstrate here that, after autophagy-dependent
STING delivery of TANK-binding kinase 1 (TBK1) to
endosomal/lysosomal compartments and activation
of transcription factors interferon regulatory factor
3 (IRF3) and NF-kB, STING is subsequently phos-
phorylated by serine/threonine UNC-51-like kinase
(ULK1/ATG1), and IRF3 function is suppressed.
ULK1 activation occurred following disassociation
from its repressor AMP activated protein kinase
(AMPK) and was elicited by CDNs generated by the
cGAMP synthase, cGAS. Thus, although CDNs may
initially facilitate STING function, they subsequently
trigger negative-feedback control of STING activity,
thus preventing the persistent transcription of innate
immune genes.
INTRODUCTION
Host cells have evolved a variety of mechanisms to recognize
and eliminate invading microbes, including developing the
ability to recognize pathogen-associated proteins and nucleic
acid and subsequently invoke powerful cellular signaling events
that stimulate the production of innate immune genes (Blasius
and Beutler, 2010; Kawai and Akira, 2011; Tamura et al., 2008).
Such defenses include the Toll-like receptors (TLR), the RIG-I
(RLR) family of receptors and nucleotide-binding domain, and
leucine-rich repeat-containing (NLR) receptors that sense
microbial molecules such as CpGDNA, viral RNAs, and lipopoly-
saccharides (Blasius and Beutler, 2010; Kawai and Akira, 2011;
Tamura et al., 2008). In addition, an endoplasmic reticulum
(ER)-associated molecule referred to as stimulator of interferon
genes (STING) has recently been shown to control a new sensing688 Cell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc.pathway that is essential for detecting aberrant cytosolic DNA
species and for triggering the production of host defense
genes such as type I interferon (IFN) (Ishikawa and Barber,
2008; Ishikawa et al., 2009).
The activation of STING (also referred to as TMEM 173/
MPYS/MITA/ERIS) may involve direct association with cytosolic
DNA species as well as with cyclic dinucleotides (cyclic diguano-
sine monophosphate [GMP] or AMP) generated directly from
certain intracellular bacteria or via a DNA-binding protein
cGAS (cGAMP synthase, also known as male abnormal 21
domain containing 1 [Mab-21 domain containing1/MB21D1] or
C6orf150) (Burdette et al., 2011; Diner et al., 2013; Jin et al.,
2008; Sun et al., 2009, 2013; Woodward et al., 2010; Zhong
et al., 2008). However, following the detection of cytosolic
DNA, cGAS utilizes GTP and ATP to generate noncanonical 20
to 50 cyclic GMP-AMP (cGAMP) rather than 30 to 50 canonical
cyclic dinucleotide species generally generated by bacteria
(Ablasser et al., 2013; Civril et al., 2013; Gao et al., 2013; Kran-
zusch et al., 2013; Zhang et al., 2013). Activated STING, accom-
panied by TANK-binding kinase 1 (TBK1), then undergoes
dramatic autophagy-related trafficking involving ATG9 and
associates with endosomes containing the transcription factors
interferon regulatory factor 3 (IRF3) and NF-kB (Ishikawa et al.,
2009; Saitoh et al., 2009). Phosphorylated IRF3 and activated
NF-kB translocate to the nucleus to initiate the transcription of
numerous innate immune genes, including IFN and members
of the IFIT family (Abe et al., 2013).
However, although STING has been shown to be essential for
the protection of the host against DNA pathogens, sustained
STING stimulation, such as by self-DNA, has also been shown
to be responsible for lethal inflammatory disease in at least two
murine models (DnaseII/ and DnaseIII/Trex1/) and plausibly
may therefore play a key role in inflammatory/autoimmune dis-
ease in humans (Ahn et al., 2012; Gall et al., 2012). Thus,
although STING is essential for initiating host defense counter
measures, chronic STING activity needs to be controlled to
avoid the deleterious consequences that sustained innate
immune gene induction would have upon the host. Here, we
demonstrate that, after activation and trafficking, STING is
phosphorylated by UNC-51-like kinase (ULK1). This occurs
following ULK1 dissociation from its repressor AMPK and was
found to be triggered by cGAS-generated CDNs. Therefore,
although CDNs may initially facilitate STING activity, they also
initiate a negative-feedback control mechanism to thwart
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Figure 1. Phosphorylation of STING S366 Inhibits Type I IFN Production in dsDNA Signaling
(A) hTERT-BJ1 cells were transfected with dsDNA (4 mg/ml) or poly I:C (4 mg/ml) using lipofectamine 2000 for 16 hr. IFNb level was measured by ELISA.
(B) hTERT-BJ1 cells were transfected with dsDNA or poly I:C as described in Figure 1A for the indicated times, and STING was detected by immunoblot.
(C and D) hTERT-BJ1 cells were incubated with ethanol (vehicle) or BFA (0.05 mg/ml) for 1 hr and then transfected with dsDNA (4 mg/ml) for the indicated times (C)
or 6 hr (D). Immunoblot (C) or immunostaining (D) was performedwith the indicated antibodies; lack of LC3 processing (bottom band) indicated loss of autophagy.
(E) hTERT-BJ1 cells were treated with siRNA (NS, nonspecific siRNA) for 3 days and then transfected with dsDNA (4 mg/ml) for 6 hr. Immunostaining was
performed with the indicated antibodies.
(F) Immunoblot was performed to confirm knockdown efficiency of ULK1 and VPS34.
(G) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 mg/ml) for 16 hr, and IFNb was measured by ELISA.
(H) Alignment of STING amino acid sequences. Highlighted amino acids indicate dsDNA-dependent phosphorylated serines, as detected by mass spectrometry.
(I) Primary Sting/MEF cells were reconstituted with STING variants using retroviruses. The cells were transfected with dsDNA (4 mg/ml) or poly I:C (4 mg/ml) for
16 hr, and IFNb was measured by ELISA.
(J) hTERT-BJ1 cells were transfected with HA-tagged mutant hSTING for 36 hr and immunostained with the indicated antibodies.
Asterisks indicate significant difference (p < 0.05) compared to NS determined by Student’s t test. Error bars indicate SD. See also Figure S1.prolonged innate immune gene transcription and to prevent
inflammatory disorders.
RESULTS
Phosphorylation of S366 Inhibits STING Function
Previously, we observed that STING activation by DNA invoked
trafficking that resembled autophagy and resulted in the delivery
of STING/TBK1 to endosomal/lysosomal regions to activate the
transcription factors NF-kB and IRF3/7 (Ishikawa et al., 2009;Saitoh et al., 2009). As an extension of these findings, we have
now determined that these events lead to an increase in the
molecular weight of STING and subsequently to the degradation
of STING within 12 hr (Figures 1A and 1B). The observed shift
in molecular weight was likely due to phosphorylation because
phosphatase treatment eliminated this modification (Figures
S1A and S1B available online). Phosphorylation likely occurred
after trafficking from the ER through the Golgi because Brefeldin
A (BFA), which inhibited STING movement, also prevented the
phosphorylation event (Figures 1C, 1D, and S1C). DegradationCell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc. 689
of STING occurred in the lysosomal compartment because
chloroquine, which inhibits lysosomal degradation, prevented
STING degradation (Figure S1D). To further evaluate the
autophagy process, we suppressed VPS34 (class III phosphaty-
linositol 3-kinase, PI3K), Beclin-1, or the serine/threonine protein
kinase ULK1 (ATG1) expression, which are considered important
components required for the autophagy process in response
to nutrient deprivation (Tooze et al., 2010). We noted that RNAi
suppression of VPS34, but not ULK1 or Beclin-1, inhibited
STING trafficking, indicating ULK1-independent processes
reminiscent of noncanonical autophagy reported for TLR9 acti-
vation in response to phagocytosed DNA associated with auto-
antibodies (Figures 1E, 1F, and S1E) (Henault et al., 2012).
Accordingly, suppression of VPS34, but not ULK1, inhibited
the ability of double-stranded DNA (dsDNA) to activate STING-
dependent type I IFN induction (Figures 1F and 1G). Indeed,
we observed that suppression of ULK1 appeared to augment
the production of type I IFN. These observations indicate that
STING recognition of dsDNA triggers a transient nonconven-
tional autophagy-related process required for IRF3/7 and NF-
kB activation.
However, after autophagy, little is known relating to the iden-
tity of kinases involved in STING phosphorylation and regulation.
To start to evaluate the role of phosphorylation in STING func-
tion, we purified STING from dsDNA-treated and untreated
hTERT-BJ1 cells using affinity purification processes. Nonactive
STING or phosphorylated STING was examined by mass spec-
trometry. These experiments indicated that STING purified only
from dsDNA-treated cells was phosphorylated in vivo on four
sites (S345, S358, S366, and S379) (Figures 1H, S1F, and
S1G). STING phosphorylation was not observed in resting, un-
treated cells (data not shown). Of the phosphorylation sites,
S358 and S366 appeared to be highly conserved in mammalian
cells (Figure 1H). To evaluate the role of these residues in STING
function, each serine was individually or collectively substituted
for alanine or aspartic acid and was transduced by retrovirus into
Sting/ MEFs prior to treatment with dsDNA. This analysis
confirmed that S366A had greatly reduced ability to induce
type I IFN (Figures 1I, S2A, and S2B) (Tanaka and Chen, 2012).
However, we additionally observed that substitution of S366 to
S366D to mimic constitutive phosphorylation also rendered
STING unable to stimulate the production of type I IFN (Figure 1I).
Substitution of the other serines to aspartic acid did not appre-
ciably affect STING function except partially in the case of
S358D. We further noted that S366A or S366D was able to traffic
normally in response to cytosolic dsDNA, suggesting that phos-
phorylation of S366 does not affect STING trafficking and likely
occurs post-Golgi trafficking (Figure 1J). We conclude that phos-
phorylation of S366 (S365 in murine STING) occurs after auto-
phagy and may negatively regulate STING activity to prevent
sustained type I IFN production following activation by cytosolic
dsDNA.
The IRF3 Pathway, but Not the NF-kB Pathway, Is
Preferentially Inhibited by STING S366D
Type I IFN production requires the coordinated activation of a
number of transcription factors, such as NF-kB as well as
IRF3 (Tamura et al., 2008). To evaluate whether both the IRF3690 Cell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc.and the NF-kB pathways were affected by phosphorylation of
S366, wild-type murine STING, STING-S365A, or STING-
S365D were transfected into 293T cells with luciferase reporter
constructs under control of IFNb, NF-kB, or IRF3 (pRD III-I)
responsive promoter elements. This study indicated that phos-
phomimetic STING-S365D failed to activate the IFNb promoter
and the IRF3 promoter, but not the NF-kB promoter (Figure 2A).
Similarly, only STING variants with an S366 substitution failed to
activate the pRD III-I promoter, but not the NF-kB promoter, indi-
cating the importance of S366 in IRF3 stimulation (Figure 2B).
The mutational change appeared to be S366 specific because
residues substituted either side of S366 (I365A and G367A) did
not influence STING function (Figure S2C). Accordingly, immu-
nohistochemical analysis indicated the translocation of the p65
subunit of NF-kB, but not of IRF3, into the nucleus of Sting/
MEF cells when reconstituted with S365D and treated with
dsDNA (Figure 2C). STING is required to transport TBK1 to endo-
somal regions for association with IRF3 (Ishikawa et al., 2009).
Immunoblot analysis of reconstituted Sting/ MEF cells
treated with dsDNA demonstrated TBK1 phosphorylation, but
not phosphorylation of IRF3 (Figure 2D). Immunoblot analysis
also indicated that murine S365D electrophoresed at a similar
size to that of naturally phosphorylated STING, suggesting that
the change in molecular weight occurring as a result of dsDNA
activationwaspartly related toS365phosphorylation (Figure 2D).
Thus, S365 phosphorylation does not appear to affect TBK1
activity but rather affects IRF3 phosphorylation. To extend this
analysis further, we stably reconstituted Sting/ MEFs with
wild-type STING or STING S365D and treated the cells with
dsDNA before carrying out a microarray analysis. This analysis
confirmed significant suppression of type I IFN production as
well as other cytosolic DNA-mediated, STING-dependent
genes, including members of the IFIT family (Figures 2E and
2F). However, the expression of a number of genes such as
TNFAIP3 remained unaffected by phosphorylation of STING on
S366 in the presence of cytosolic dsDNA, presumably because
they only require NF-kB for transcriptional activation and not
both IRF3/7 and NF-kB, as does the transcription of type I IFN
(Figure 2G). Compared to the S365D variant, STING S365A
was considerably more inactive, suggesting that the former
does not simply function as a phosphomutant (Figure S2D).
Our data confirm that phosphorylation of STING on S366
strongly prevents the transcriptional activity of IRF3.
ULK1 and 2 Are Responsible for Phosphorylating STING
on S366
To attempt to identify the kinase responsible for phosphorylation
of S366, we utilized a high-throughput approach and analyzed
the ability of 272 purified serine/threonine kinases to in vitro
phosphorylate a 9 amino acid peptide containing this residue
(ELLISGMEK) (Figure 3A). We found that ULK1 and ULK2, key
serine/threonine kinases involved in autophagy regulation, phos-
phorylated S366 to high specificity compared to all other kinases
examined (17.1- and 21.13-fold respectively) (Mizushima, 2010).
To confirm this finding, we carried out an in vitro kinase assay
using purified STING and ULK1 and examined STING-related
phosphorylation events by autoradiography following SDS-
PAGE electrophoresis. Phosphorylation of STING was reduced
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Figure 2. Phosphorylation of S366 of STING Inhibits IRF3 Activity, but Not NF-kB Activity
(A and B) HEK293T cells were transfected with plasmids encoding the luciferase gene under control of the indicated promoter with STING variants. After 36 hr,
luciferase activity was measured.
(C) Primary Sting/ MEF cells were reconstituted with mSTING variants using retroviruses. The cells were transfected with dsDNA (4 mg/ml) for 3 hr and then
stained with the indicated antibodies.
(D) Reconstituted Sting/ MEF cells were transfected with dsDNA (4 mg/ml) for the indicated times, and immunoblots were performed.
(E) Reconstituted Sting/ MEF cells were transfected with dsDNA (4 mg/ml) for 3 hr. RNA was purified and examined for gene expression with Illumina Sentrix
BeadChip Array (Mouse WG6 version2). Pseudocolors indicate transcript levels below, equal to, or above the mean (green, black, and red, respectively). The
scale represents the intensity of gene expression (log10 scale). The results shown here are representative of three independent experiments.
(F) Real-time PCR was carried out with the indicated probes to confirm gene array analysis shown in Figure 2E. Total RNA was extracted from reconstituted
Sting/ MEF cells after dsDNA treatment for 3 hr, and then cDNA was synthesized.
(G) The expression of NF-kB target genes in Sting/ MEF with S365D was comparable with that in Sting/ MEF with mSTING. Promoter sequence of listed
genes (1,000 to +200) was obtained through DBTSS (http://dbtss.hgc.jp) and analyzed by TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) at
threshold score 85. The results shown here are the averages of three independent experiments.
Asterisks indicate significant difference (p < 0.05) determined by Student’s t test. ns means not significant. Error bars indicate SD. See also Figure S2.using a STINGS336A variant (Figures 3B and 3C). To additionally
verify this, we isolated ULK1-phosphorylated STING from
SDS-PAGE gels and determined the phosphorylation site(s) by
mass spectrometry. This approach confirmed phosphorylationof STING by ULK1 and additionally demonstrated that this
event only occurred on S366 and on no other serine or threonine
residues (Figure 3D). As a control, we similarly examined the
ability of TBK1 to posttranslationally modify STING and did notCell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc. 691
Figure 3. ULK1 Negatively Regulates IFNb Production by Phos-
phorylating STING S366
(A) ELLISGMEK, which includes Ser366, was used as substrate to identify
ULK1 and ULK2.
(B) Schematic of human ULK1. KD is kinase domain.
(C) In vitro kinase assay was performed with recombinant ULK1 protein using
recombinant hSTING protein as substrate. The indicated serine sites that were
identified by mass spectrometry were substituted with alanine.
(D) Recombinant hSTING protein was incubated with recombinant ULK1 in
the presence of ATP for 15 min. Phosphorylated STING was analyzed by
mass spectrometry. Highlighted amino acid (S366) was identified as the only
phosphorylation site.
(E and F) Primary MEF cells (E) or hTERT-BJ1 cells (F) were treated with
siRNA as indicated (NS, nonspecific siRNA) and then transfected with dsDNA
(4 mg/ml) for 16 hr. IFNb was measured by ELISA. Knockdown efficiency of
ULK1 in primary MEF cells was confirmed by immunoblot.
(G) siRNA-treated primary MEF cells were infected with HSV-1 (MOI = 0.1) for
24 hr, and then plaque assay was performed.
(H) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 mg/ml)
for the indicated times, and then immunoblot was performed.
692 Cell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc.observe any phosphorylation events, indicating that STING is
likely not a substrate for TBK1, at least in vitro (Figures S3A–
S3C). Collectively, these data indicate that ULK1/2 can phos-
phorylate STING on S366.
To evaluate these findings further, we RNAi suppressed
ULK1, ULK2, or both in MEF cells treated with dsDNA and
measured type I IFN production. We found, using MEF cells,
that suppression of STING expression significantly abrogated
IFN production in response to dsDNA signaling and confirmed
that ULK1 suppression lead to elevated levels of type I IFN
production presumably because IRF3 function is maintained
(Figure 3E). Similar observations were seen when suppressing
ULK1 expression in hTERT-BJ1 cells (Figure 3F). Suppression
of ULK2 had less effect, probably because we did not observe
significant ULK2 expression, at least in hTERT-BJ1 or MEF
cells (Figures S3D and S3E). ULK1 and 2 were also observed
to be robustly expressed in primary human dendritic cells (Fig-
ure S3F). Suppression of ULK1 expression in MEF cells was
also seen to inhibit herpes simplex virus type I (HSV1) replica-
tion, likely due to elevated type I IFN exerting antiviral effects
(Figures 3G and S3G). Immunoblot analysis of ULK1-specific
RNAi-treated hTERT-BJ1 cells indicated that STING was not
degraded as efficiently as in control cells, suggesting that
phosphorylation on this site may also play a role in facilitating
STING degradation (Figure 3H). STING also shifted in size
due to alternate phosphorylation events, plausibly involving
the other three serine sites that we discovered by proteomic
approaches (Figure 1H). Slightly sustained TBK1 and IRF3
phosphorylation was also observed in the absence of ULK1,
perhaps indicating that the presence of STING facilitates
TBK1 stability. As shown earlier, loss of ULK1 did not affect
STING-dependent autophagy, as additionally emphasized by
evident LC3-II conversion (Figures 1C and 3H). Our data indi-
cate that ULK1 and perhaps ULK2, depending on whether a
particular cell expresses ULK2, are able to phosphorylate
STING on S366 to perhaps facilitate STING degradation as
well as prevent IRF3 translocation.
AMPK, Not mTOR, Is the Master Regulator
of ULK1/2 Activity
The mechanisms whereby ULK1 is regulated are complex
though are known to involve control by AMPK and mammalian
target of rapamycin (mTOR) (Alers et al., 2012). AMPK is a heter-
otrimeric protein and key energy-sensing kinase that is activated
by environmental stress such as Ca2+ efflux or ATP consump-
tion. Under nonstressful conditions, AMPK T172 is maintained
in a phosphorylated state by upstream AMPK kinases such as
LKB1 and Ca2+-calmodulin dependent protein kinase-kinase-b
(CaMKK b) (Alexander and Walker, 2011). Constitutively phos-
phorylated AMPK in turn phosphorylates ULK1 on S556, which
maintains ULK1 in an inactive state. However, additional
posttranslational modifications of AMPK following cell stress
releases it from association with ULK1 with concomitant lossAsterisks indicate significant difference (p < 0.05) compared to NS determined
by Student’s t test. ns, not significant. Error bars indicate SD. See also
Figure S3.
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Figure 4. dsDNA Induces the Dephosphorylation of AMPK T172
and ULK1 S556
(A and B) hTERT-BJ1 cells were transfected with dsDNA (4 mg/ml) (A) or in-
fected with HSV-1 g34.5 (MOI = 10) (B) for the indicated times, and then
immunoblot was carried out with the indicated antibodies.
(C) HEK293T cells were cotransfected with plasmids encoding luciferase
driven by the IFNb promoter as well as hSTING and ULK1 variants. After 36 hr,
luciferase activity was measured.
Error bars indicate SD. See also Figure S4.
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(A) hTERT-BJ1 cells were treated with DMSO (vehicle) or compound C (10 mM)
for 1 hr prior to dsDNA transfection (4 mg/ml) for the indicated times. Immu-
noblot was performed with the indicated antibodies.
(B) hTERT-BJ1 cells were treated with DMSO or compound C as described in
Figure 5A and then transfected with dsDNA (4 mg/ml) for 6 hr. cDNA was
synthesized from total RNA, and then real-time PCR was performed with a
probe for Ifnb.
(C) hTERT-BJ1 cells were treated with siRNA for NS (nonspecific siRNA) or
LKB1 and then transfected with dsDNA (4 mg/ml) for the indicated times.
Immunoblot was performed with the indicated antibodies.
(D) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 mg/ml) for
16 hr. IFNb was measured by ELISA.
(E and F) hTERT-BJ1 cells were treated with compound C as described in
Figure 5A (E) or siRNA for LKB1 as described in Figure 5C (F). Confocal
analysis of STING trafficking in response to dsDNA (4 mg/ml) was carried out
using anti-STING antibody.
Asterisks indicate significant difference (p < 0.05) compared to vehicle (B)
or NS (D) determined by Student’s t test. Error bars indicate SD. See also
Figure S5.of ULK1 S556 phosphorylation (Alers et al., 2012). This enables
ULK1 to phosphorylate target proteins. Similarly, mTOR, which
can be activated by amino acid deprivation, likewise regulates
ULK1 activity through phosphorylation but targets S758 (Mizush-
ima, 2010). Given this, we examined the control of ULK1 phos-
phorylation by these two pathways. When treated with dsDNA,
we noted that phosphorylation of ULK1 S758 was relatively un-
affected following dsDNA treatment (Figure 4A). However, we
observed that phosphorylation of AMPKa T172 was dramatically
reduced in the presence of cytosolic DNA, which corresponded
to a reduction of S556 on ULK1 (Figure 4A). The effect induced
by dsDNA was also seen following infection with HSV1 (Fig-
ure 4B). In contrast, vesicular stomatitis virus (VSV) did not
induce dephosphorylation of AMPK T172 or ULK1 S556 (Fig-
ure S4A). Constitutively active ULK1 (S556D) was observed to
enhance the ability of STING to stimulate transcription of the
IFN promoter, unlike ULK1 S556A, presumably because ULK1
S556D is maintained in an inactive, phosphorylated state, which
fails to impede IRF3 function (Figure 4C). The kinase activity
of ULK1 was confirmed to be required for the regulation
of STING (Figure S4B). Inhibition of AMPK by compound C
substantiated that ULK1 S556 phosphorylation was an AMPK-
dependent event because this process was completely negated
by this drug (Figure 5A). Accordingly, compound C thusCell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc. 693
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Figure 6. cGAS Is Required for the Negative
Regulation of STING through the AMPK-
ULK1 Axis
(A andB) hTERT-BJ1 cells were treatedwith siRNA
for NS (nonspecific), STING (A), and cGAS (B) for
3 days and then transfected with dsDNA (4 mg/ml)
for the indicated times. Immunoblot was per-
formed with the indicated antibodies.
(C) Knockdown efficiency of cGAS in hTERT-BJ1
cells was confirmed by real-time PCR.
(D) siRNA-treated hTERT-BJ1 cells were trans-
fected with dsDNA for 6 hr as described in
Figure 6A. STING trafficking was observed by
confocal microscopy.
(E) siRNA-treated hTERT-BJ1 cells were trans-
fected with dsDNA (4 mg/ml) for 16 hr. IFNb was
measured by ELISA.
Asterisks indicate significant difference (p < 0.05)
compared to NS determined by Student’s t test.
Error bars indicate SD. See also Figure S6.suppressed dsDNA-dependent, but not significantly dsRNA-
dependent type I IFN, induction (Figures 5A, 5B, and S5A). We
observed that AMPK inhibition facilitated STING stability, similar
to loss of ULK1, again indicating that phosphorylation of STING
affects its degradation (Figure 5A). Moreover, levels of IRF3 were
maintained and did not undergo rapid degradation, presumably
because phosphorylated IRF3 did not translocate and was not
efficiently degraded (Figures 5A and S5B). Conversely, activa-
tion of AMPK was also seen to modestly enhance type I IFN
production (Figure S6D).
Given these findings, we next evaluated the roles of the AMPK
kinases, CaMKK b and LKB1 in cytosolic dsDNA signaling. We
observed that suppression of CaMKK b somewhat reduced
the phosphorylation status of AMPK T172, but ULK1 S556
phosphorylation was maintained under resting conditions and
underwent dephosphorylation in the presence of cytosolic
DNA, suggesting that a kinase other than CaMKK bmay be pre-
dominantly involved in the regulation of AMPKT172 (Figures S5D
and S5E). In addition, we noted that cytosolic DNA also induced
the phosphorylation of LKB1 on S428 and that this was also
dependent on AMPK (Figures 5A and S5C). To further investigate
the role of LKB1 in AMPK/ULK1 activity, we used RNAi to sup-
press LKB1 expression. Loss of LKB1 completely eliminated
ULK1 S556 phosphorylation under resting conditions, indicating
that LKB1 was largely responsible for maintaining AMPK T172
phosphorylation and for limiting ULK1 activity (Figure 5C). Loss
of LKB1 was also observed to inhibit dsDNA-dependent type I
IFN induction, similar to compound C (Figure 5D). These events
were predominantly dsDNA specific and did not occur using694 Cell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc.lipofectamine alone (Figure S5F). It was
also observed that loss of LKB1 or
AMPK activity did not affect STING auto-
phagy, suggesting that AMPK control
of ULK1 occurs in autophagosome/endo-
somal regions after STING trafficking
(Figures 5E and 5F). Our data indicate
that LKB1 predominantly maintains phos-phorylation of AMPK on T172, an event that is disrupted by the
presence of cytosolic DNA, leading to ULK1 activation and
STING phosphorylation.
cGAMPs Regulate AMPK
The activation of AMPK has been reported to be dependent
on nutrient deprivation, fluctuations in calcium levels, and/or
increases in AMP/ATP ratios. However, we did not notice sig-
nificant fluctuations in the levels of these regulators (data not
shown). We also observed that loss of STING in hTERT-BJ1 cells
did not affect the phosphorylation of AMPK on T172 or ULK1 on
S556, indicating that the control of ULK1 phosphorylation by
cytosolic DNA was a STING-independent event (Figure 6A).
However, loss of STING impeded cytosolic DNA-mediated
autophagy and prevented LKB1 phosphorylation by AMPK on
S428. BFA also prevented LKB1 phosphorylation by AMPK by
similarly impeding autophagy-related trafficking (Figure S6A).
We confirmed that, although STING was required for cytosolic
DNA-mediated autophagy, it was not necessary for rapamycin-
dependent autophagy (Figure S6B).
To further understand the triggering of AMPK/ULK1 activity,
we used RNAi to suppress the synthase cGAS, which has
been reported to associate with cytoplasmic DNA and to
generate cyclic dinucleotides that are capable of binding to
and facilitating STING function. Surprisingly, we observed
that loss of cGAS prevented AMPK T172 dephosphorylation
and, subsequently, ULK1 S566 dephosphorylation (Figures 6B
and 6C). STING-dependent autophagy was also prevented
by loss of cGAS in hTERT-BJ1 cells, in response to dsDNA
A0 3 6 9
Sting+/+
12 0 3 6 9 12 (h)
pAMPK  (T172)
AMPK
pULK1 (S555)
ULK1
pTBK1
TBK1
pIRF3
IRF3
STING
Actin
LKB1
pLKB1 (S431)
Primary MEF
Sting-/-
cGAMP (Canonical):
B Primary MEF
RNAi:
Control dsDNA
IF
N
 (p
g/
m
l) 
*
cGAMP 
(Canonical)
* *
*
C
0 3 6 9
Sting+/+
12 0 3 6 9 12
pAMPK  (T172)
AMPK
pULK1 (S555)
ULK1
pTBK1
TBK1
pIRF3
IRF3
STING
Actin
LKB1
pLKB1 (S431)
(h)
Primary MEF
cGAMP (Non-canonical ):
Sting-/-
D
0 3 6 9
NS
12 0 3 6 9 12
cGAS
pAMPK  (T172)
AMPK
pULK1 (S556)
ULK1
pTBK1
TBK1
pIRF3
IRF3
STING
Actin
LKB1
pLKB1 (S428)
(h)
hTERT-BJ1
RNAi:
cGAMP (Non-canonical ):
E
0 
100 
200 
300 
400 
500 
600 
700 
800 
N
S
 
S
TI
N
G
 
U
LK
1 
N
S
 
S
TI
N
G
 
U
LK
1 
N
S
 
S
TI
N
G
 
U
LK
1 
N
S
 
S
TI
N
G
 
U
LK
1 
Poly I:C
LKB1
AMPK
P 
T172 
ULK1
P 
S556 
STING 
cGAS 
dsDNA LKB1
AMPK
S428 
ULK1
P 
STING 
TBK1
P 
IRF3
P 
cGAMP
Activation
Inhibition
cGAMP
inactive 
active 
TBK1
STING 
TBK1
P S366 
P 
gene expression 
Figure 7. cGAMPs Activate AMPK-ULK1
Control of STING
(A) Primary Sting+/+ and Sting/ MEF cells were
transfected with canonical cGAMP (30 to 50 cGAMP)
(8 mg/ml) using lipofectamine 2000 for the indicated
times. Immunoblot was performed with the indi-
cated antibodies.
(B) Primary MEF cells were treated with siRNA for
NS (nonspecific), STING, or ULK1 for 3 days and
then transfected with dsDNA (4 mg/ml), canonical
cGAMP (8 mg/ml), or poly I:C (4 mg/ml) as described
in Figure 7A for 16 hr. IFNbwas measured by ELISA.
(C) Primary Sting+/+ and Sting/ MEF cells were
transfected with noncanonical cGAMP (20 to 50
cGAMP) (8 mg/ml) as described in Figure 7A for the
indicated times. Western blot was performed with
the indicated antibodies.
(D) hTERT-BJ1 cells were treated with siRNA for
NS or cGAS for 3 days and then transfected with
noncanonical cGAMP (8 mg/ml) as described in
Figure 7A for the indicated times. Immunoblot was
performed with the indicated antibodies.
(E) Model of STING activation by cytosolic DNA
and subsequent inhibition by ULK1.
Asterisks indicate significant difference (p < 0.05)
compared to NS determined by Student’s t test.
Error bars indicate SD. See also Figure S6.(Figures 6D and 6E). These results suggested a role for cGAS
and the generation of cyclic dinucleotides in the regulation of
AMPK activity. To extend our studies, we next examined
whether cGAMP could activate the AMPK/ULK1 pathway in
mouse embryonic fibroblast (MEF) cells. This analysis confirmed
that canonical and noncanonical cGAMP alone could trigger
the dephosphorylation of AMPK and ULK1 on T172 and S555,
respectively (Figures 7A–7C). This event did not require STING,
as previously shown (Figures 6A and 7A). Similar to our obser-
vations with dsDNA, loss of ULK1 enhanced cGAMP’s ability
to induce type I IFN. However, we notice that cyclic dinucleo-
tides are not as robust activators of STING-dependent innate
immune signaling when compared to dsDNA (Figure 7B). WeCell 155, 688–69next treated hTERT-BJ1 cells with non-
canonical cGAMP to evaluate whether
these dinucleotides could similarly activate
the AMPK/ULK1 regulatory pathway. In
hTERT-BJ1 cells, the amino acid sequence
of STING is H232, which cannot bind
readily to canonical cyclic dinucleotides
such as c-di-AMP, c-di-GMP, or cGAMP
(Ablasser et al., 2013; Civril et al., 2013;
Gao et al., 2013; Kranzusch et al., 2013;
Zhang et al., 2013). In most other types
of human cells, such as THP-1, the amino
acid sequence of STING is R232, which
can bind readily to canonical cyclic dinu-
cleotides. This analysis demonstrated
that, comparable to MEF cells, noncanon-
ical cGAMP triggered the dephosphory-
lation of AMPK T172 and ULK1 S556 inhTERT-BJ1 cells (Figure 7D). In addition, noncanonical cGAMP
also stimulated the phosphorylation of TBK1 and IRF3 in
hTERT-BJ1 cells, albeit weaker than in comparison with dsDNA
(Figure 7D). Noncanonical cGAMP was observed to induce
STING trafficking in both primary MEF cells and hTERT-BJ1
cells, whereas canonical cGAMP activated STING only in MEF
cells (Figure S6C). Collectively, our data indicate that cGAS is
essential for the activation of AMPK/ULK1 suppression of STING
(Figure 6B) and that cGAMPs are responsible for triggering the
dephosphorylation of AMPK T172 and activation of ULK1, which
phosphorylates STING on S366 to impede its activity (Figure 7E).
Thus, cyclic dinucleotides, although facilitating STING function,
provide a means to control STING via a negative-feedback loop.8, October 24, 2013 ª2013 Elsevier Inc. 695
DISCUSSION
Our data demonstrate that, in the presence of cytosolic DNA,
STING rapidly traffics with TBK1 via VPS34-related autophago-
somes to associate with endosomal compartments containing
NF-kB and IRF3. This triggers the production of numerous
cytokines and chemokines that can regulate the adaptive im-
mune response (Abe et al., 2013; Ishikawa and Barber, 2008;
Ishikawa et al., 2009). This event appears to be independent of
ULK1 and is reminiscent of a noncanonical autophagy-related
process involving plasmacytoid dendritic cell (pDC)-mediated
phagocytosis of antinuclear antibody bound to CpG DNA
(DNA-immune complexes, DNA-IC) (Henault et al., 2012).
Following DNA-IC engulfment, autophagy facilitates DNA-
dependent TLR9 trafficking to cellular compartments harboring
IRF3 and NF-kB. Our data here indicate a similar mechanism
of type I IFN induction that is dependent on STING and that
is triggered by non-CpG DNA species. Aside from being
ULK1 independent, STING-dependent autophagosomes do
not have double-membrane structures and are dependent on
ATG9a (Ishikawa et al., 2009; Saitoh et al., 2009). After traf-
ficking, STING is phosphorylated and degraded, presumably
to avoid the deleterious consequences that sustained innate im-
mune gene induction can have upon the host (Ahn et al., 2012).
Our data here indicate that the phosphorylation of STING occurs
after the formation of autophagosomes and trafficking through
the Golgi and predominantly occurs on four serine residues
as determined bymass spectrophotometry. Subsequent studies
indicated that phosphorylation of S366 was found to inhibit
STING-dependent IRF3 activity, but not robustly NF-kB. Indeed,
the mechanisms whereby STING controls NF-kB activity remain
to be determined. We note that phosphorylation of S366 may
also facilitate STING degradation to additionally prevent sus-
tained function. It is not clear why the three remaining serine sites
are targeted for phosphorylation. However, our data suggest
that they do not strongly affect STING function but more likely
influence STING turnover to ensure that the presence of STING
is not lasting. It was also noted that STING longevity (for
example, achieved by expression of STING S366A that could
not be phosphorylated or suppression of ULK1) corresponded
with a decrease in the degradation of phosphorylated TBK1.
Thus, STING appears to be phosphorylated in autophago-
some/endosomal compartments and degraded, a consequence
that enables the proteolytic degradation of phosphorylated
TBK1 after it has phosphorylated IRF3. A STING variant
(S366A), unable to be phosphorylated, in contrast appears to
shield TBK1 from degradation and to largely prevent the phos-
phorylation and translocation of IRF3 by mechanisms that
remain to be clarified. However, it is possible that phosphory-
lated TBK1 may require release from STING to be able to target
IRF3. The mechanisms of how STING/VPS34 preautophago-
somal structures (PAS) are initiated are also unknown and will
be the focus of further study.
Using a serine/threonine kinase library, we determined that,
after trafficking, STINGS366was predominantly phosphorylated
by the mammalian C. elegans uncoordinated-51 (UNC-51)-like
kinase ULK1 (ATG1) and ULK2, first identified as important
components of the autophagy process in yeast (Alers et al.,696 Cell 155, 688–698, October 24, 2013 ª2013 Elsevier Inc.2012; Mizushima, 2010; Tooze et al., 2010). Mammalian ULK1
shares 50% homology with ULK2, and the loss of both
completely blocks amino acid starvation-induced autophagy in
murine embryonic fibroblasts (Alers et al., 2012). ULK1 appears
to be more ubiquitously expressed than ULK2 and exists in a
complex with ATG13 and RB1CC1. The major energy sensor,
MTOR, as a complex with RAPTOR andMLST8 (MTOR complex
1; MTORC1), directly phosphorylates ULK1 on S758 under
nutrient-rich conditions, an event that likely sequesters ULK1 in
an inactive state through association with RAPTOR. Inhibition
of the MTOR complex by rapamycin, for example, is sufficient
to induce autophagy (Alers et al., 2012; Mizushima, 2010). How-
ever, we did not see any dephosphorylation of ULK1 S758
in cytosolic DNA-treated cells. Moreover, rapamycin-dependent
autophagy was observed to occur independently of STING,
unlike cytosolic DNA-mediated autophagy, which did require
STING. In contrast, we did observe dephosphorylation— which
is controlled by another key energy sensor, AMPK—of ULK1
S556 in hTERT-BJ1 andMEF cells (Hardie et al., 2012). In this sit-
uation, AMPK, which exists as a heterotrimeric protein (a, b, g)
can be targeted by a number of kinases such as CaMKK b, which
responds to fluctuations in calcium levels, or by liver kinase B1
(LKB1; also referred to as serine/threonine kinase 11, STK11),
which responds to fluctuations in ADP and AMP. LKB1 similarly
exists in a trimeric complex with the pseudokinase STRAD and
the adaptor protein MO25 (Alexander and Walker, 2011). Phos-
phorylation of AMPK by CaMMK b or LKB1 causes the dephos-
phorylation of T172 and prevents AMPK from phosphorylating
ULK1 on S556. However, our data indicated that, in response
to cytosolic DNA, relatively low fluctuations in Ca2+ or AMP levels
were measurable, suggesting that other modes of AMPK T172
dephosphorylation were responsible. Nevertheless, we did
note that LKB1 was essential for AMPK phosphorylation on
T172. This leads us to consider alternate mechanisms of
LKB1/AMPK/ULK1 control and to investigate the role of cyclic
dinucleotides in this process. First, we found a key role for the
synthase cGAS in AMPK dephosphorylation in response to
cytosolic DNA. Concomitantly, we observed that canonical or
noncanonical cyclic dinucleotides can themselves directly
cause the dephosphorylation of AMPK T172 and ULK1 S556 in
a STING or cGAS-independent manner. Thus, cGAS is likely
responsible for generating cyclic dinucleotides from cytosolic
DNA, which facilitates STING activity. In addition, cGAS-gener-
ated cGAMPs provide amechanism for the subsequent negative
control of STING that occurs after trafficking and delivery of
TBK1 to cellular compartments containing IRF3 and NF-kB. It
is not yet clear how cyclic dinucleotides activate the LKB1/
AMPK/ULK1 axis. However, the cyclic nucleotide cAMP has
been reported to regulate the Epac (exchange protein directly
activated by cAMP) family, which are guanine nucleotide ex-
change factors (GEFs) able to influence LKB1-mediated control
of AMPK T172 phosphorylation (Fu et al., 2011). Relatively
few cyclic dinucleotide-binding proteins have thus far been
reported, and so the identification of the cGAMP regulators of
AMPK activity remains to elucidated. In summary, cyclic dinucle-
otide control of AMPK/ULK1 and STING helps ensure that sus-
tained production of STING-dependent proinflammatory genes
is prevented, events that may otherwise lead to inflammation
and autoimmune disorders (Ahn et al., 2012; Gall et al., 2012).
Our data provide information on the control of DNA-mediated
innate immune signaling pathways that could conceivably be
therapeutically targeted to help prevent a variety of self-DNA-
triggered disorders.EXPERIMENTAL PROCEDURES
Cells, Reagents, and Viruses
Primary Sting+/+ and Sting/ MEF cells were prepared as described
(Ishikawa and Barber, 2008). Tbk1/ MEF cells were kindly provided by
W.C. Yeh. HEK293T cells, Platinum-E retroviral packaging cell line, hTERT-
BJ1 cells, and primary human dendritic cells were purchased from the
American Type Cell culture (ATCC), Cell Biolabs, Clontech, and Stemcell,
respectively. MEF cells, HEK293T cells, and Platinum-E cells were cultured
in DMEM supplemented with 10% FBS and antibiotics. hTERT-BJ1 cells
were cultured in a 4:1 ratio of DMEM: Medium 199 with 10% FBS, 1 mM
sodium pyruvate, and 4mML-glutamine. Poly I:Cwas obtained fromAmerican
Biosciences. Interferon stimulatory DNA (ISD) (90-mer), used as dsDNA in this
study, was prepared as described previously (Ishikawa and Barber, 2008).
Canonical cGAMP (30 to 50 cGAMP) and noncanonical cGAMP (20 to 50 cGAMP)
were purchased from Invivogen and BioLog, respectively. BFA, compound C,
rapamycin, and STO-609 were purchased from SIGMA. Nonspecific siRNA
(NS), siRNA for STING, ULK1, ULK2, LKB1, cGAS, VPS34, and Beclin-1
were purchased from Dharmacon. Lipofectamine 2000 and lipofectamine
RNAiMAX were purchased from Invitrogen. Anti-STING rabbit polyclonal
antibody was prepared as described previously (Ishikawa and Barber, 2008).
Other antibodies used in this paper were as follows: anti-b-actin (SIGMA,
A5441); anti-calreticulin (Abcam, ab14234); anti-IRF3 (Invitrogen, 39-2700,
used for murine IRF3); anti-IRF3 (Santa Cruz Biotechnology, sc-9082); anti-
phospho-IRF3 (Cell Signaling, 4947); anti-p65 (Cell Signaling, 3987); anti-TBK1
(Abcam, ab40676); anti-phospho-TBK1 (Cell Signaling, 5483); anti-LC3A
(Cell Signaling, 4599); anti-ULK1 (Cell Signaling, 4773); anti-phospho-ULK1
(Ser556) (Cell Signaling, 5869); anti-phospho-ULK1 (Ser758) (Cell Signaling,
6888); anti-ULK2 (Abcam, ab97695); anti-AMPKa (Cell Signaling, 5832); anti-
phospho-AMPKa (Thr172) (Cell Signaling, 2535); anti-VPS34 (Cell Signaling,
4263); anti-Beclin-1 (Cell Signaling, 3495); anti-LKB1 (Cell Signaling, 3047);
anti-phospho LKB1 (Ser428) (Abcam, ab63473); and anti-HA (SIGMA,
H9658). HSV-1 (KOS strain) was purchased from ATCC. HSV-1 g34.5 was
kindly provided by Bernard Roizman. HSV-1 luc was kindly provided by
David Leib. Purified ULK1 and TBK1 were purchased from SIGMA and Milli-
pore, respectively. Probe for Ulk1, Ulk2, Infb, Ifit3, Ifna4, Tnfaip3, and cgas
was purchased from Applied Biosystems.
Proteomics
hTERT-BJ1 cells in ten 15 cm dishes were used for untreated samples,
dsDNA-treated samples, and negative controls (untreated and precipitated
with mouse IgG), respectively. The cells were transfected with 5 mg/ml of
dsDNA for 6 hr. After that, the cells were lysed in TNE buffer (50 mM Tris
[pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% NP-40) with protease and phospha-
tase inhibitors and then subjected to immunoprecipitation with monoclonal
anti-STING antibody covalently conjugated beads for 18 hr at 4C. After
washing with TNE buffer, STING protein was eluted using Elution buffer (pH
2.8, Thermo) and then neutralized by Tris-HCl (pH 9.5). The samples were
boiled in SDS-sample buffer and then separated in a 7.5% acrylamide gel.
The gel was stained with CBB staining kit (Thermo), and the visualized bands,
including STING, were analyzed by microcapillary reverse-phase HPLC
nanoelectrospray tandem mass spectrometry (mLC/MS/MS) at the Harvard
Mass Spectrometry and Proteomics Resource Laboratory.
Reconstitution of Sting/ MEF Cells
Platinum-E retroviral packaging cells were transfected with pBabe-STING-
puro using Lipofectamine 2000. After 2 days, the supernatants containing
retrovirus were collected. Sting/MEF cells were incubated with the superna-
tants in the presence of 10 mg/ml of polybrene (SIGMA) for 6 hr. After another2 days, 2 mg/ml of puromycin (SIGMA) was added to culture media to remove
uninfected cells.
In Vitro Kinase Assay
181–379 of hSTING was cloned into pET-26b and expressed in BL21 (DE3).
Recombinant hSTING protein was isolated using HisPur Ni-NTA Resin
(Thermo) and eluted with imidazole. 60 ng of hSTING protein was incubated
with 20 ng of GST-ULK1 in 20 mM Tris-HCl (pH 7.5), 25 mM KCl, 0.1 mM
EDTA, 1 mM DTT, 5% glycerol, 2 mM MgCl2, 2 mM MnCl2, 1.25 mM ATP,
and 0.3 mg/ml BSA in presence of [g-32P] ATP (Perkin Elmer) for 15 min at
30C. The samples were boiled in SDS-sample buffer and separated in a
7.5% acrylamide gel. After running the gel, gel was fixed in 40% methanol
solution with 10% acetic acid and stained with CBB staining kit (Thermo). After
destaining, the dried gel was exposed to BioMax Light Film (Kodak).
Kinase Screening
To identify the kinase that phosphorylates residue Ser366 of STING, a screen
of 272 recombinant protein kinases was performed at KINEXUS (Vancouver,
Canada). Briefly, peptide S366 (ELLISGMEK) or A366 (ELLIAGMEK) was
mixed with individual protein kinases in the presence of [g-33P] ATP. After
removing unreacted [g-33P] ATP from the reaction, radioactivity was quantified
in a scintillation counter. The radioactivity of S366 was compared with that
of A366.
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